JP2013525338A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525338A5
JP2013525338A5 JP2013505534A JP2013505534A JP2013525338A5 JP 2013525338 A5 JP2013525338 A5 JP 2013525338A5 JP 2013505534 A JP2013505534 A JP 2013505534A JP 2013505534 A JP2013505534 A JP 2013505534A JP 2013525338 A5 JP2013525338 A5 JP 2013525338A5
Authority
JP
Japan
Prior art keywords
active
ingredient
fluticasone
active pharmaceutical
propionate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013505534A
Other languages
English (en)
Japanese (ja)
Other versions
JP6347608B2 (ja
JP2013525338A (ja
Filing date
Publication date
Priority claimed from PT105058A external-priority patent/PT105058B/pt
Application filed filed Critical
Publication of JP2013525338A publication Critical patent/JP2013525338A/ja
Publication of JP2013525338A5 publication Critical patent/JP2013525338A5/ja
Application granted granted Critical
Publication of JP6347608B2 publication Critical patent/JP6347608B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013505534A 2010-04-21 2011-04-21 医薬品有効成分の粒子加工のための方法 Active JP6347608B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT105058A PT105058B (pt) 2010-04-21 2010-04-21 Processo para processamento de partículas de ingredientes activos farmacêuticos
PT105058 2010-04-21
PCT/GB2011/000631 WO2011131947A2 (en) 2010-04-21 2011-04-21 A process for particle processing of active pharmaceutical ingredients

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016176303A Division JP6857467B2 (ja) 2010-04-21 2016-09-09 医薬品有効成分の粒子加工のための方法

Publications (3)

Publication Number Publication Date
JP2013525338A JP2013525338A (ja) 2013-06-20
JP2013525338A5 true JP2013525338A5 (enExample) 2013-11-07
JP6347608B2 JP6347608B2 (ja) 2018-06-27

Family

ID=44194836

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013505534A Active JP6347608B2 (ja) 2010-04-21 2011-04-21 医薬品有効成分の粒子加工のための方法
JP2016176303A Active JP6857467B2 (ja) 2010-04-21 2016-09-09 医薬品有効成分の粒子加工のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016176303A Active JP6857467B2 (ja) 2010-04-21 2016-09-09 医薬品有効成分の粒子加工のための方法

Country Status (13)

Country Link
US (1) US9956144B2 (enExample)
EP (1) EP2560620B1 (enExample)
JP (2) JP6347608B2 (enExample)
CN (1) CN102970978B (enExample)
BR (1) BR112012026941A2 (enExample)
CA (1) CA2796978C (enExample)
IL (1) IL222596B (enExample)
MX (1) MX338594B (enExample)
PL (1) PL2560620T3 (enExample)
PT (1) PT105058B (enExample)
RU (1) RU2597790C2 (enExample)
SG (1) SG185003A1 (enExample)
WO (1) WO2011131947A2 (enExample)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691145B2 (en) 2009-11-16 2014-04-08 Flodesign Sonics, Inc. Ultrasound and acoustophoresis for water purification
US10993879B2 (en) 2010-02-08 2021-05-04 Shenzhen Evergreen Therapeutics Co., Ltd. Pulmonary delivery of progestogen
CN102811730B (zh) 2010-02-08 2014-07-09 杜涛 孕激素作为糖皮质激素增敏剂的使用
US10987361B2 (en) 2010-02-08 2021-04-27 Shenzhen Evergreen Therapeutics Co., Ltd. Treating auto-immune and auto-inflammatory diseases
US9421553B2 (en) 2010-08-23 2016-08-23 Flodesign Sonics, Inc. High-volume fast separation of multi-phase components in fluid suspensions
US9745548B2 (en) 2012-03-15 2017-08-29 Flodesign Sonics, Inc. Acoustic perfusion devices
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US9752114B2 (en) 2012-03-15 2017-09-05 Flodesign Sonics, Inc Bioreactor using acoustic standing waves
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US9783775B2 (en) 2012-03-15 2017-10-10 Flodesign Sonics, Inc. Bioreactor using acoustic standing waves
US9752113B2 (en) 2012-03-15 2017-09-05 Flodesign Sonics, Inc. Acoustic perfusion devices
US9567559B2 (en) 2012-03-15 2017-02-14 Flodesign Sonics, Inc. Bioreactor using acoustic standing waves
US9688958B2 (en) 2012-03-15 2017-06-27 Flodesign Sonics, Inc. Acoustic bioreactor processes
US10370635B2 (en) 2012-03-15 2019-08-06 Flodesign Sonics, Inc. Acoustic separation of T cells
US10322949B2 (en) 2012-03-15 2019-06-18 Flodesign Sonics, Inc. Transducer and reflector configurations for an acoustophoretic device
US10689609B2 (en) 2012-03-15 2020-06-23 Flodesign Sonics, Inc. Acoustic bioreactor processes
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US9272234B2 (en) 2012-03-15 2016-03-01 Flodesign Sonics, Inc. Separation of multi-component fluid through ultrasonic acoustophoresis
US9796956B2 (en) 2013-11-06 2017-10-24 Flodesign Sonics, Inc. Multi-stage acoustophoresis device
PT106237B (pt) 2012-03-30 2015-03-19 Hovione Farmaci Ncia S A Produção de partículas substancialmente monodispersas utilizando moagem e separação por membranas
US10737953B2 (en) 2012-04-20 2020-08-11 Flodesign Sonics, Inc. Acoustophoretic method for use in bioreactors
US11324873B2 (en) 2012-04-20 2022-05-10 Flodesign Sonics, Inc. Acoustic blood separation processes and devices
PT106738B (pt) * 2013-01-09 2015-06-08 Hovione Farmaciencia Sa Método para o controlo do fenómeno de degradação difusional de ostwald (ostwald ripening) no processamento de partículas de um ingrediente farmacêutico
CN105339064B (zh) * 2013-04-25 2017-06-16 弗洛设计声能学公司 赋形剂从药物样品中的去除
US9745569B2 (en) 2013-09-13 2017-08-29 Flodesign Sonics, Inc. System for generating high concentration factors for low cell density suspensions
KR102256576B1 (ko) 2013-10-08 2021-05-27 에이아이 테라퓨틱스, 인코포레이티드 림프관평활근종증의 치료를 위한 라파마이신
US9725710B2 (en) 2014-01-08 2017-08-08 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
PT107433B (pt) * 2014-01-28 2018-12-04 Hovione Farm S A Processo de redução e controlo do tamanho de partícula
RU2016136348A (ru) 2014-02-11 2018-03-16 Лэм Терапьютикс, Инк. Рапамицин для лечения лимфангиолейомиоматоза
US10307371B2 (en) 2014-02-11 2019-06-04 AI Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
PT107567B (pt) * 2014-03-31 2019-02-13 Hovione Farm S A Secador por atomização com atomizador múltiplo, método para o aumento de escala de pós para inalação secos por dispositivo de atomização múltiplo e uso de vários atomizadores num secador por atomização
PL3125875T3 (pl) 2014-04-04 2023-11-20 AI Therapeutics, Inc. Nadający się do inhalacji preparat rapamycyny do leczenia stanów związanych z wiekiem
US9744483B2 (en) 2014-07-02 2017-08-29 Flodesign Sonics, Inc. Large scale acoustic separation device
AU2015330905B2 (en) 2014-10-07 2021-02-25 AI Therapeutics, Inc. An inhalable rapamycin formulation for the treatment of pulmonary hypertension
MA40910A (fr) 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
WO2016130645A1 (en) 2015-02-10 2016-08-18 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
US10106770B2 (en) 2015-03-24 2018-10-23 Flodesign Sonics, Inc. Methods and apparatus for particle aggregation using acoustic standing waves
PT108368B (pt) 2015-03-31 2018-11-05 Hovione Farm S A Produção contínua de partículas
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US10640760B2 (en) 2016-05-03 2020-05-05 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
WO2016176663A1 (en) 2015-04-29 2016-11-03 Flodesign Sonics, Inc. Acoustophoretic device for angled wave particle deflection
BR112017024713B1 (pt) 2015-05-20 2022-09-27 Flodesign Sonics, Inc Método para a separação de um segundo fluido ou um particulado de um fluido principal
WO2016201385A2 (en) 2015-06-11 2016-12-15 Flodesign Sonics, Inc. Acoustic methods for separation cells and pathogens
WO2016205334A1 (en) 2015-06-16 2016-12-22 Vascular Strategies Llc Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
EP3319739B1 (en) 2015-07-09 2021-03-31 Flodesign Sonics Inc. Non-planar and non-symmetrical piezolectric crystals and reflectors
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
PT109030B (pt) 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
US10710006B2 (en) 2016-04-25 2020-07-14 Flodesign Sonics, Inc. Piezoelectric transducer for generation of an acoustic standing wave
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
KR20190127655A (ko) 2016-10-19 2019-11-13 프로디자인 소닉스, 인크. 음향학에 의한 친화성 세포 추출
JP2021507561A (ja) 2017-12-14 2021-02-22 フロデザイン ソニックス， インク．Ｆｌｏｄｅｓｉｇｎ Ｓｏｎｉｃｓ， Ｉｎｃ． 音響トランスデューサドライバ及びコントローラ
IL309073A (en) 2021-06-03 2024-02-01 Arcadia Medicine Inc Enantiomeric entactogen compounds and methods of their use.
WO2024009079A1 (en) 2022-07-04 2024-01-11 Hovione Scientia Limited Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
WO2025064867A1 (en) * 2023-09-21 2025-03-27 Yuva Biosciences, Inc. Delivery system for mitochondrial health enhancers
WO2026038127A1 (en) 2024-08-13 2026-02-19 Lupin Limited A process for processing micronized active pharmaceutical ingredients

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2091360C (en) 1990-09-10 1997-04-08 Pui-Ho Yuen Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
US6187765B1 (en) 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
US6184765B1 (en) * 1999-01-07 2001-02-06 Nec Research Institute, Inc. Switch useful at superconducting temperatures and comprising superconducting material
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
GB9925934D0 (en) 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
JP4684545B2 (ja) 2002-09-26 2011-05-18 大日本住友製薬株式会社 溶出性の良好なイソキサゾール誘導体経口製剤
HUE028288T2 (en) 2004-03-31 2016-12-28 Toyama Chemical Co Ltd Fine dispersion of sparingly soluble drug and process for producing the same
EP1595534A1 (en) * 2004-05-13 2005-11-16 Universiteit Utrecht Holding B.V. Gel composition comprising charged polymers
KR20070100735A (ko) * 2004-12-17 2007-10-11 씨아이피엘에이 엘티디. 약학적 화합물 및 조성물
WO2006073154A1 (ja) 2005-01-07 2006-07-13 Eisai R&D Management Co., Ltd. 医薬組成物及びその製造方法
US20060193818A1 (en) * 2005-02-25 2006-08-31 Southall Michael D Compositions containing amines and use thereof
DE102005011786A1 (de) 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
GB0523576D0 (en) 2005-11-18 2005-12-28 Theradeas Ltd Drug composition and its use in therapy
US20070178051A1 (en) 2006-01-27 2007-08-02 Elan Pharma International, Ltd. Sterilized nanoparticulate glucocorticosteroid formulations
LT2170279T (lt) * 2007-07-31 2018-03-12 Otsuka Pharmaceutical Co., Ltd. Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai
EP2050437A1 (en) 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
EP2156823A1 (en) * 2008-08-14 2010-02-24 Pharmatex Italia Srl Process for the preparation of sterile powdered pharmeceutical compounds in the form of micro and nanoparticles

Similar Documents

Publication Publication Date Title
JP2013525338A5 (enExample)
JP2017019845A5 (enExample)
US9956144B2 (en) Process for particle processing of active pharmaceutical ingredients
US20130319411A1 (en) Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
JP2018199684A (ja) Ｒ（＋）ブデソニド及び１以上の気管支拡張剤を含む医薬組成物
AU2008334547B2 (en) Organic compounds
MXPA05006441A (es) Preparacion de suspensiones acuosas esteriles que comprenden ingredientes activos cristalinos micronizados para inhalacion.
CN105120841A (zh) 抗毒蕈碱化合物的粒度减小
JP2019501876A5 (enExample)
JP2018537453A5 (enExample)
KR20100099281A (ko) 유기 화합물
US20150352077A1 (en) Multi-Component Crystalline Particles for Inhalation Therapy
CN103347518A (zh) 含有抗毒蕈碱药物的无推进剂液体制剂
JP7254130B2 (ja) 結晶多形および医薬組成物
JP6653323B2 (ja) 吸入可能な製剤
ES2831019T3 (es) Un procedimiento para el procesamiento de partículas de ingredientes farmacéuticos activos
CN103536582A (zh) 罗氟司特干粉吸入剂
HK1216302B (zh) 抗毒蕈硷化合物的粒度减小